What is the address of MEDSABOR?

The registered office of MEDSABOR is located at Rue du Tombois(TH) 9, 6500 Beaumont.

Is MEDSABOR still active?

Yes. According to the CBE (30 October 2026) MEDSABOR is active, legal situation “Normale toestand”, started on 8 March 1999.

Is MEDSABOR registered on Peppol?

Yes, MEDSABOR is registered on the Peppol network with ID 0208:0465584063.

What is the enterprise number of MEDSABOR?

The enterprise number of MEDSABOR is BE0465584063.

When was MEDSABOR founded?

MEDSABOR was founded on 8 March 1999.

Who are the directors of MEDSABOR?

According to the 2025 annual accounts, the directors of MEDSABOR are: Rachid SABOR.

Is MEDSABOR a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 March 1999; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did MEDSABOR make in 2025?

MEDSABOR posted a profit after taxes of € 28,998 in financial year 2025.

What is the revenue of MEDSABOR?

As a small company, MEDSABOR is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 22,089.

MEDSABOR (Private Limited) - Beaumont - BE0465584063

Dossier MEDSABOR, printed on 30 October 2026 from databakkes.be/en/0465584063/medsabor. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

MEDSABOR from Beaumont, company number BE0465584063, closed financial year 2025 with a result of € 28,998 after tax. For that financial year MEDSABOR recorded a gross margin of € 22,089 and equity of € 173,103. Compared with financial year 2024, the result moved from € 9,003 to € 28,998. Profitable, and profit is growing. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on August 31, 2026.

What it is worth Healthy

€ 173,103

▼ 48% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 28,998

▲ 222% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 6,363

▼ 80% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 191,000 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 336

▼ 31% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 9,886

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 58,745 Gross margin 2022: € 58,745 First fiscal year in the series	€ 25,724 Gross margin 2023: € 25,724 ▼ 56% vs 2022 (€ 58,745) Unfavourable step	€ 11,956 Gross margin 2024: € 11,956 ▼ 54% vs 2023 (€ 25,724) Unfavourable step	€ 22,089 Gross margin 2025: € 22,089 ▲ 85% vs 2024 (€ 11,956) Favourable step	▲ 85%
Profit after taxes	€ 4,562 Profit after taxes 2022: € 4,562 First fiscal year in the series	€ 6,284 Profit after taxes 2023: € 6,284 ▲ 38% vs 2022 (€ 4,562) Favourable step	€ 9,003 Profit after taxes 2024: € 9,003 ▲ 43% vs 2023 (€ 6,284) Favourable step	€ 28,998 Profit after taxes 2025: € 28,998 ▲ 222% vs 2024 (€ 9,003) Favourable step	▲ 222%
Equity	€ 319,817 Equity 2022: € 319,817 First fiscal year in the series	€ 326,101 Equity 2023: € 326,101 ▲ 2% vs 2022 (€ 319,817) Favourable step	€ 335,104 Equity 2024: € 335,104 ▲ 3% vs 2023 (€ 326,101) Favourable step	€ 173,103 Equity 2025: € 173,103 ▼ 48% vs 2024 (€ 335,104) Unfavourable step	▼ 48%
Total debts	€ 17,663 Total debts 2022: € 17,663 First fiscal year in the series	€ 220 Total debts 2023: € 220 ▼ 99% vs 2022 (€ 17,663) Favourable step	€ 484 Total debts 2024: € 484 ▲ 120% vs 2023 (€ 220) Unfavourable step	€ 10,222 Total debts 2025: € 10,222 ▲ € 9,738 vs 2024 (€ 484) Unfavourable step	▲ € 9,738
Cash	€ 17,663 Cash 2022: € 17,663 First fiscal year in the series	€ 4,541 Cash 2023: € 4,541 ▼ 74% vs 2022 (€ 17,663) Unfavourable step	€ 32,522 Cash 2024: € 32,522 ▲ € 27,981 vs 2023 (€ 4,541) Favourable step	€ 6,363 Cash 2025: € 6,363 ▼ 80% vs 2024 (€ 32,522) Unfavourable step	▼ 80%
Land & buildings	-	€ 4,201 Land & buildings 2023: € 4,201 First fiscal year in the series	€ 3,605 Land & buildings 2024: € 3,605 ▼ 14% vs 2023 (€ 4,201) Unchanged	€ 2,163 Land & buildings 2025: € 2,163 ▼ 40% vs 2024 (€ 3,605) Unchanged	▼ 40%
Retained profit	€ 307,420 Retained profit 2022: € 307,420 First fiscal year in the series	€ 313,704 Retained profit 2023: € 313,704 ▲ 2% vs 2022 (€ 307,420) Favourable step	€ 322,707 Retained profit 2024: € 322,707 ▲ 3% vs 2023 (€ 313,704) Favourable step	€ 160,705 Retained profit 2025: € 160,705 ▼ 50% vs 2024 (€ 322,707) Unfavourable step	▼ 50%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 191,000 Dividend 2025: € 191,000 Unchanged (€ 0) Unchanged
Bank debt	€ 2,046 Bank debt 2022: € 2,046 First fiscal year in the series	€ 0 Bank debt 2023: € 0 ▼ 100% vs 2022 (€ 2,046) Favourable step	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 337,481 Balance sheet total 2022: € 337,481 First fiscal year in the series	€ 326,321 Balance sheet total 2023: € 326,321 ▼ 3% vs 2022 (€ 337,481) Unchanged	€ 335,588 Balance sheet total 2024: € 335,588 ▲ 3% vs 2023 (€ 326,321) Unchanged	€ 183,324 Balance sheet total 2025: € 183,324 ▼ 45% vs 2024 (€ 335,588) Unchanged	▼ 45%

Key figures of MEDSABOR, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to MEDSABOR?

What happened at MEDSABOR in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Aug 31, 2026 New annual accounts for financial year 2025: profit of € 28,998 (▲ 222% vs 2024). filed late Source: NBB ↗
Mar 8, 1999 Start of the company according to the CBE. KBO
Feb 22, 1999 New establishment in Beaumont. KBO

In short

From € 4,562 profit in 2022 to € 28,998 profit in 2025.

Paid € 27,675 in corporate taxes since 2022.

Best year ever: 2025, with € 28,998 profit.

Paid out € 191,000 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Management

Rachid SABOR

MEDSABOR

Behind MEDSABOR is Rachid SABOR.

Directors

According to the 2025 annual accounts

Rachid SABOR

Manager

Establishments

Establishment units

Physical locations of this company

Registered office

Rue du Tombois(TH) 9

6500 Beaumont

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0465.584.063
VAT number: BE 0465.584.063
Registered office: Rue du Tombois(TH) 9, 6500 Beaumont
Names & denominations: MEDSABOR
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 March 1999
Peppol: Active · Active since 11 Oct 2026

View on CBE Public ↗ Annual accounts (NBB) ↗